Search Results 791-800 of 13935 for Assay

  1. Pediatrics Clinical Trials - Medical Professionals

    This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...

  2. Rajiv K. K. Pruthi, M.B.B.S. - Mayo Clinic Faculty Profiles

    His training in molecular biology provides unique insights into the molecular pathology of coagulation disorders and development of clinical assays for ...

  3. Publications - Kevin C. Halling, M.D., Ph.D. - Mayo Clinic

    ... Assay as a First-Approach Test. J Mol Diagn. 2025 Dec; 27 (12):1213-1223 ... Clinical Validation of the TruSight Oncology 500 Assay for the Detection and ...

  4. Kirk J. Wangensteen, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    This model enables the disruption of gene function in many genes using a parallel genetic assay with a CRISPR-Cas9 system that Dr. Wangensteen and ...

  5. Genetic Testing Clinical Trials - Mayo Clinic Research

    ... assayed from blood of cases with CAP and controls without history of cancer. A Study to Improve the Use of Genetic Testing in Disease Prevention and ...

  6. Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative - Mayo Clinic

    The assay must have been performed locally by a Clinical Laboratory Improvement Act (CLIA) (or equivalent) certified laboratory. The type of assay will be ...

  7. Blood Transfusion Clinical Trials - Mayo Clinic Research

    Laboratory Assay Optimization 2.0 Rochester, MN. The purpose of this study is to better understand the role of HIV and/or HCV infection and/or SARS-CoV-2 on ...

  8. A Study To Evaluate Effectiveness And Safety Of Deucravacitinib (BMS-986165) Compared With Placebo In Participants With Active Systemic Lupus Erythematosus - Mayo Clinic

    - D-glucan assay. Other protocol-defined inclusion/exclusion criteria apply. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility ...

  9. Precision diagnosis of MOG antibody-associated disease is critical for timely, targeted therapy - Mayo Clinic

    "Early availability of the live cell–based MOG assay at Mayo Clinic, before it was widely accessible in the U.S., resulted in an unparallelled cohort of ...

  10. A Study Of Tucatinib With Trastuzumab And MFOLFOX6 Versus Standard Of Care Treatment In First-line HER2+ Metastatic Colorectal Cancer (MOUNTAINEER-03) - Mayo Clinic

    - HER2+ disease as determined by a tissue based assay performed at a central laboratory. - Participant has rat sarcoma viral oncogene homolog wild-type (RAS ...